Left Ventricular Contractility and Wall Stress in Patients With Aortic Stenosis With Preserved or Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Left Ventricular Contractility and Wall Stress in Patients With Aortic Stenosis With Preserved or Reduced Ejection Fraction

Published:2020-02 Issue:2 Volume:13 Page:357-369
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Ito Saki,Pislaru Cristina,Miranda William R.,Nkomo Vuyisile T.,Connolly Heidi M.,Pislaru Sorin V.,Pellikka Patricia A.,Lewis Bradley R.,Carabello Blase A.,Oh Jae K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference34 articles.

1. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators;Connolly;Circulation,1997

2. Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery;Tarantini;Eur J Cardiothorac Surg,2003

3. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis;Taniguchi;J Am Coll Cardiol Intv,2018

4. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Nishimura;J Am Coll Cardiol,2014

5. Reduced left ventricular ejection fraction in patients with aortic stenosis;Ito;J Am Coll Cardiol,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke volume index (SVI) predicts all-cause mortality following transcatheter aortic valve replacement (TAVR);Cardiovascular Revascularization Medicine;2024-06

2. Quantifying the Survival Loss Linked to Late Therapeutic Indication in High-Gradient Severe Aortic Stenosis;JACC: Advances;2024-03

3. Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations;Frontiers in Cardiovascular Medicine;2024-02-07

4. Predictors of outcome in patients with moderate mixed aortic valve disease;Heart;2023-12-26

5. Penalized Model‐Based Unsupervised Phenomapping Unravels Distinctive HFrEF Phenotypes With Improved Outcomes Discrimination From Sacubitril/Valsartan Treatment Independent of MAGGIC Score;Journal of the American Heart Association;2023-09-19